Stoke Therapeutics, Inc. (NASDAQ: STOK), a cutting-edge player in the biotechnology sector, is capturing investor attention with its groundbreaking approach to addressing severe genetic diseases. With a current market capitalization..
Definitive Healthcare Corp. (NASDAQ: DH), a key player in the healthcare information services industry, offers a unique software-as-a-service (SaaS) healthcare commercial intelligence platform. This Massachusetts-based company, founded in 2011, provides..
Sonida Senior Living, Inc. (SNDA), a prominent player in the healthcare sector, operates within the medical care facilities industry, specializing in providing a range of senior housing solutions across the..
InnovAge Holding Corp. (NASDAQ: INNV) is a notable player in the healthcare sector, specifically in the medical care facilities industry. Based in Denver, Colorado, InnovAge is a provider of comprehensive..
Investors eyeing the healthcare sector might find iRadimed Corporation (IRMD) an intriguing opportunity, given its specialized niche in the medical devices industry. With a market capitalization of $1.17 billion, this..
Oculis Holding AG (NASDAQ: OCS), a Switzerland-based clinical-stage biopharmaceutical company, is attracting significant attention from investors with its robust pipeline of drug candidates targeting ophthalmic and neurological diseases. The company’s..
Orthofix Medical Inc. (NASDAQ: OFIX), a prominent player in the healthcare sector, particularly in the medical devices industry, presents an intriguing opportunity for investors seeking exposure to the medical technology..
Maze Therapeutics, Inc. (NASDAQ: MAZE), a clinical-stage biopharmaceutical company, is garnering significant attention in the investment community for its promising prospects in the biotechnology sector. Specializing in the development of..
Altimmune, Inc. (NASDAQ: ALT), a biopharmaceutical company making strides in the treatment of liver diseases, has captured the attention of investors with its notable 412.82% potential upside. As the company..
Capricor Therapeutics, Inc. (NASDAQ: CAPR) is capturing attention in the biotechnology sector with its promising pipeline focused on transformative cell and exosome-based therapies. Headquartered in San Diego, California, this clinical-stage..
Beta Bionics, Inc. (NASDAQ: BBNX), a promising player in the healthcare sector, specifically within the medical devices industry, is making waves with its innovative solutions for managing diabetes. With a..
Intellia Therapeutics, Inc. (NASDAQ: NTLA), a prominent player in the biotechnology sector, is making waves with its groundbreaking work in curative genome editing treatments. As a clinical-stage company, Intellia is..
Weave Communications, Inc. (NASDAQ: WEAV) offers an intriguing opportunity for investors seeking exposure in the healthcare technology sector. With a market capitalization of $419.98 million, Weave Communications has carved out..
HealthStream, Inc. (NASDAQ: HSTM) stands as a prominent player in the healthcare information services sector, providing an array of Software-as-a-Service (SaaS) solutions tailored for healthcare organizations across the United States...
AxoGen, Inc. (NASDAQ: AXGN), a key player in the medical devices industry, is drawing significant investor attention with its focus on peripheral nerve regeneration and repair technologies. Headquartered in Alachua,..
Arvinas, Inc. (NASDAQ: ARVN) is capturing the attention of investors seeking transformative opportunities in the biotechnology sector. With a market capitalization of $706.47 million, this clinical-stage biotechnology company is focused..
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) is generating considerable buzz among investors with its strong potential upside of 28.6%, according to recent analyst ratings. This clinical-stage pharmaceutical company, headquartered in Cambridge,..
Akebia Therapeutics, Inc. (NASDAQ: AKBA) is turning heads in the healthcare investment community, with its promising potential upside of 225.93% spotlighting the biopharmaceutical company as a significant player in the..
Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) is capturing the attention of investors with its promising potential upside of 82.07%, as revealed by recent analyst ratings. Headquartered in Chicago, Illinois, this..
